Find clinical trials for Triple Negative Breast Cancer in San Antonio, TX

This is a 3-arm study stratified by plasma ctDNA. Patients with residual TNBC disease after pre-operative therapy will be assigned to 1 of 3 Arms bas...

or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after su...

This study will assess the efficacy and safety of Niraparib in participants with either tumor mutation in the BRCA gene (tBRCAmut) HER2- breast...

to assess the safety, tolerability, and pharmacokinetics, and to identify the optimal dose of ADRX-0706 in patients with select advanced solid tumors...

levels in combination with chemotherapeutic agents in the first- and second-line treatment of participants with locally advanced/metastatic triple...

This study is one single group of participants with non-small cell lung cancer (NSCLC) who have not been cured by other treatments. It is th...

This is a Phase III, randomised, open-label, 2 arm, multicentre, international study assessing the efficacy and safety of Dato-DXd compared with ICC...

previously untreated, locally advanced, inoperable or metastatic triple-negative breast cancer whose tumors...

after induction with first-line chemotherapy plus pembrolizumab in triple negative breast cancer (TNBC). The prim...

with previously untreated, locally advanced inoperable or metastatic triple-negative breast cancer, whose tumors...